Kanaph Therapeutics focuses on global technology transfers and clinical data; "We will overcome our weaknesses"
Predicted impact: Low
General IR and technology-transfer messaging; no new contract size or financial figures.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.